SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-20-000023
Filing Date
2020-01-22
Accepted
2020-01-22 16:04:45
Documents
3
Period of Report
2020-01-20
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rgbp012220form8k.htm 8-K 21338
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 3576
3 EXHIBIT 99.2 ex99_2.htm EX-99.2 3864
  Complete submission text file 0001607062-20-000023.txt   30027
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 20538967
SIC: 2834 Pharmaceutical Preparations